Company intelligence / Profile preview
Pattern Computer
Friday Harbor, Washington, United Statespatterncomputer.com ↗
- Ownership
- Private
- Employees
- ~26
- Development stage
- Other
01
Overview
Pattern Computer has identified promising gene-expression patterns and developed drug combinations for TNBC and ovarian cancer currently in vitro and early testing; the ProSpectral™ device is in late-stage development for rapid, highly accurate disease detection including Covid-19, with expected FDA-compliant differentiation between major respiratory infections[1][6].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeDeviceDrug combinations (repurposed/FDA-approved drugs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Fred Hutch Cancer Center (colorectal cancer research)[1]Undisclosed Wall Street firms (for financial RC/XAI application)[5]
Beyond the preview
Go deeper on Pattern Computer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pattern Computer.